blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2583717

EP2583717 - Methods and devices for renal nerve blocking [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.12.2019
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  18.01.2019
FormerGrant of patent is intended
Status updated on  22.08.2018
FormerExamination is in progress
Status updated on  06.07.2018
FormerGrant of patent is intended
Status updated on  22.02.2018
FormerExamination is in progress
Status updated on  08.09.2017
Most recent event   Tooltip09.07.2021Lapse of the patent in a contracting state
New state(s): HU
published on 11.08.2021  [2021/32]
Applicant(s)For all designated states
Medtronic Ardian Luxembourg S.à.r.l.
102, rue des Maraîchers
2124 Luxembourg / LU
[2018/33]
Former [2018/17]For all designated states
Medtronic Ardian LLC
199 Jefferson Drive
Menlo Park, CA 91025 / US
Former [2013/17]For all designated states
Ardian, Inc.
199 Jefferson Drive
Menlo Park, CA 91025 / US
Inventor(s)01 / Gelfand, Mark
304 8th Avenue, Apt. 3
New York, NY 10001 / US
02 / Levin, Howard, R.
640 Pompander Walk
Teaneck, NJ New Jersey 07666 / US
 [2013/18]
Representative(s)Zimmermann & Partner Patentanwälte mbB
Postfach 330 920
80069 München / DE
[2019/08]
Former [2013/17]Zimmermann & Partner
Josephspitalstr. 15
80331 München / DE
Application number, filing date12189194.917.11.2004
[2013/17]
Priority number, dateUS2004090019928.07.2004         Original published format: US 900199
[2013/17]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2583717
Date:24.04.2013
Language:EN
[2013/17]
Type: A3 Search report 
No.:EP2583717
Date:04.09.2013
Language:EN
[2013/36]
Type: B1 Patent specification 
No.:EP2583717
Date:20.02.2019
Language:EN
[2019/08]
Search report(s)(Supplementary) European search report - dispatched on:EP01.08.2013
ClassificationIPC:A61B5/00, A61B5/20, A61M5/172, A61M5/142, A61N1/36
[2018/09]
CPC:
A61M5/14276 (EP); A61M5/1723 (EP); A61P25/00 (EP);
A61P25/24 (EP); A61B5/201 (EP); A61B5/4041 (EP);
A61B5/6852 (EP); A61M2005/1726 (EP); A61M2210/1082 (EP);
A61N1/36017 (EP) (-)
Former IPC [2013/17]A61N1/40, A61N1/18, A61M5/142, A61M5/172
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2019/08]
Former [2013/17]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Verfahren und Vorrichtungen für die Nierennervenblockade[2013/17]
English:Methods and devices for renal nerve blocking[2013/17]
French:Procédés et dispositifs pour le blocage du nerf rénal[2013/17]
Examination procedure03.03.2014Amendment by applicant (claims and/or description)
03.03.2014Examination requested  [2014/15]
07.09.2017Despatch of a communication from the examining division (Time limit: M04)
22.12.2017Reply to a communication from the examining division
23.02.2018Communication of intention to grant the patent
04.07.2018Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
23.08.2018Communication of intention to grant the patent
28.12.2018Fee for grant paid
28.12.2018Fee for publishing/printing paid
28.12.2018Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP04822267.3  / EP1799302
Divisional application(s)EP18186547.8  / EP3417895
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040822267) is  11.04.2012
Opposition(s)21.11.2019No opposition filed within time limit [2020/05]
Fees paidRenewal fee
19.10.2012Renewal fee patent year 03
19.10.2012Renewal fee patent year 04
19.10.2012Renewal fee patent year 05
19.10.2012Renewal fee patent year 06
19.10.2012Renewal fee patent year 07
19.10.2012Renewal fee patent year 08
26.11.2012Renewal fee patent year 09
27.11.2013Renewal fee patent year 10
26.11.2014Renewal fee patent year 11
30.11.2015Renewal fee patent year 12
28.11.2016Renewal fee patent year 13
27.11.2017Renewal fee patent year 14
22.11.2018Renewal fee patent year 15
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.11.2004
AT20.02.2019
CY20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
MC20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
GB17.11.2019
LU17.11.2019
[2021/32]
Former [2021/26]AT20.02.2019
CY20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
MC20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
GB17.11.2019
LU17.11.2019
Former [2020/48]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
MC20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
GB17.11.2019
LU17.11.2019
Former [2020/36]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
MC20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
LU17.11.2019
Former [2020/35]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
LU17.11.2019
Former [2020/17]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
TR20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/13]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SI20.02.2019
SK20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/03]AT20.02.2019
CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2020/01]CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
PL20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/49]CZ20.02.2019
DK20.02.2019
EE20.02.2019
FI20.02.2019
IT20.02.2019
RO20.02.2019
SE20.02.2019
SK20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/48]DK20.02.2019
FI20.02.2019
IT20.02.2019
SE20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/46]FI20.02.2019
IT20.02.2019
SE20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/39]FI20.02.2019
SE20.02.2019
BG20.05.2019
GR21.05.2019
IS20.06.2019
PT20.06.2019
Former [2019/38]FI20.02.2019
SE20.02.2019
BG20.05.2019
GR21.05.2019
PT20.06.2019
Former [2019/37]FI20.02.2019
SE20.02.2019
GR21.05.2019
PT20.06.2019
Former [2019/34]FI20.02.2019
SE20.02.2019
PT20.06.2019
Former [2019/33]FI20.02.2019
PT20.06.2019
Documents cited:Search[XY]US2003216792  (LEVIN HOWARD R [US], et al) [X] 1-6,9-11 * paragraph [0084] - paragraph [0096]; figures 1-6 * [Y] 8;
 [YA]WO0226318  (MEDTRONIC INC [US]) [Y] 8 * page 30, line 16 - page 32, line 8 * * page 52, line 17 - page 54, line 5; figures 1-14 * [A] 1-7,9-11;
 [A]US5922340  (BERDE CHARLES B [US], et al) [A] 1-11 * column 2, line 65 - column 4, line 54 * * column 15, line 21 - column 21, line 13; figures 1-6 *;
 [XYI]US6287608  (LEVIN HOWARD R [US], et al) [X] 1-4,6,7,11 * column 5, line 4 - line 33 * * column 6, line 6 - column 9, line 35; figures 1-7 * [Y] 8 [I] 5,9,10;
 [XYI]US2003158584  (CATES ADAM W [US], et al) [X] 1-3,5,6,10 * paragraphs [0111] - [0124] - [ 145] - [0149]; figures 1-27 * [Y] 8 [I] 9;
 [A]WO9641616  (EURO CELTIQUE SA [LU], et al) [A] 1-11 * page 6, line 6 - line 20 * * page 31, line 1 - page 33, line 16 * * page 36, line 20 - page 41, line 10 *
ExaminationUS2004064129
by applicantUS4692147
 US5713847
 US5711326
 US5458631
 US4360019
 US4487603
 US4715852
 US5836935
 US4816016
 US4405305
 US5756115
 US5429634
 US5843069
 US5626862
 US3987790
 US4865845
 US5057318
 US5059423
 US5112614
 US5137727
 US5234692
 US5234693
 US5728396
 US5589192
 US5061492
 US4530840
 US5700485
 US6238702
 US5618563
 US4011861
    - "Effects of long-term renal sympathetic denervation on heart failure after myocardial infarction in rats", Heart Vessels, SPRINGER-VERLAG, (2002), vol. 16, pages 51 - 56
    - "Mechanisms of Local Anesthetics", CHARLES BERDE, Anesthesia, (2000), pages 491 - 521
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.